The antisense sequence of the HIV-1 TAR stem-loop structure covalently linked to the hairpin ribozyme enhances its catalytic activity against two artificial substrates

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 1, 1999, Pages 33-42

  Pérez Ruiz, Mercedes ^a   Sievers, Dirk ^a   García López, Pedro Antonio ^b   Berzal Herranz, Alfredo ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; RIBOZYME; SATELLITE RNA; VIRUS RNA;

ARTICLE; COVALENT BOND; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; GENE SILENCING; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NICOTIANA TABACUM; RNA VIRUSES; TOBACCO RINGSPOT VIRUS; TOBACCO RINGSPOT VIRUS SATELLITE RNA;

EID: 0032993828     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.33     Document Type: Article

References (34)

1. ALCAMÍ, J., LAÍN DE LERA, T., FOLGUEIRA, L., PEDRAZA, M.A., JACQUÉ, J.M., BACHELERIE, F., NORIEGA, A.R., HAY, R.T., HARRICH, D., GAYNOR, R.B., VIRELIZIER, J.L., and ARENZANA-SEISDEDOS, F. (1995). Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14, 1552-1560.
2. ANDERSON, P., MONFORTE, J., TRITZ, R., NESBITT, S., HEARST, J., and HAMPEL, A. (1994). Mutagenesis of the hairpin ribozyme. Nucleic Acids Res. 22, 1096-1100.
3. BERTANI, G. (1951). Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62, 293-300.
4. BERZAL-HERRANZ, A., JOSEPH, S., CHOWRIRA, B.M., BUTCHER, S.E., and BURKE, J.M. (1993). Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme. EMBO J. 12, 2567-2574.
5. BETHESDA RESEARCH LABORATORIES. (1986). BRL pUC host: E. coli DH5™ competent cells. Bethesda Res. Lab. Focus 8, 9.
6. BIASOLO, M.A., RADAELLI, A., DEL PUP, L., FRANCHIN, E., DE GIULI-MORGHEN, C., and PALÙ, G. (1996). A new tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection. J. Virol. 70, 2154-2161.
7. BUTCHER, S.E., HECKMAN, J.E., and BURKE, J.M. (1995). Reconstitution of hairpin ribozyme activity following separation of functional domains. J. Biol. Chem. 270, 29648-29651.
8. CHATTERJEE, S., JOHNSON, P.R., and WONG, K.K. (1992). Dual-target inhibition of HIV-1 in vitro by means of adeno-associated virus antisense vector. Science 258, 1485-1488.
9. ECKARDT, S., ROMBY, P., and SCZAKIEL, G. (1997). Implications of RNA structure on the annealing of a potent antisense RNA directed against the human immunodeficiency virus type 1. Biochemistry 36, 12711-12721.
10. ENGDAHL, H.M., HJALT, T.Å.H., and WAGNER, E.G.H. (1997). A two unit antisense RNA cassette test system for silencing of target genes. Nucleic Acids Res. 25, 3218-3227.
11. FELDSTEIN, P.A., BUZAYAN, J.M., and BRUENING, G. (1989). Two sequences participating in the autolytic processing of satellite tobacco ringspot virus complementary RNA. Gene 82, 53-61.
12. FENG, S., and HOLLAND, E.C. (1988). HIV-1 tat trans-activation requires the loop sequence within tar. Nature 334, 165-167.
13. HAMPEL, A., and TRITZ, R. (1989). RNA catalytic properties of the minimum (-)sTRSV sequence. Biochemistry 28, 4929-4933.
14. HANAHAN, D. (1985). Techniques for transformation of E. coli. In: DNA Cloning: A Practical Approach. D.M. Glover, ed. (IRL Press, Oxford) 1, 109-135.
15. HOMANN, M., RITTNER, K., and SCZAKIEL, G. (1993a). Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1. J. Mol. Biol. 233, 7-15.
16. HOMANN, M., TZORTZAKAKI, S., RITTNER, K., SCZAKIEL, G., and TABLER, M. (1993b). Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1. Nucleic Acids Res. 21, 2809-2814.
17. LONG D.M., and UHLENBECK, O.C. (1993). Self-cleaving catalytic RNA. FASEB J. 7, 25-30.
18. MALMGREN, C., WAGNER, E.G.H., EHRESMANN, C., EHRESMANN, B., and ROMBY, P. (1997). Antisense RNA control of plasmid R1 replication. The dominant product of the antisense RNA-mRNA binding is not a full RNA duplex. J. Biol. Chem. 272, 12508-12512.
19. MOOSBAUER, J., and TABLER, M. (1997). A helix-1 extended hairpin ribozyme exhibits altered cleavage behavior in vitro. Antisense Nucleic Acids Drug Dev. 7, 79-87.
20. MUESING, M.A., SMITH, D.H., and CAPON, D.J. (1987). Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48, 691-701.
21. OBERSTRASS, J., and NELLEN, W. (1997). Regulating genes with antisense RNA. In: Antisense Oligodeoxynucleotides and Antisense RNA. Novel Pharmacological and Therapeutic Agents. B. Weiss, ed. (CRC Press, Boca Raton, FL), pp. 171-195.
22. PENG, H., CALLISON, D., LI, P., and BURRELL, C. (1996). Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector. Virology 220, 377-389.
23. PENG, H., CALLISON, D.E., LI, P., and BURRELL, C.J. (1997). Enhancement or inhibition of HIV-1 replication by intracellular expression of sense or antisense RNA targeted at different intermediates of reverse transcription. AIDS 11, 587-595.
24. PERSSON, C., WAGNER, E.G.H., and NORDSTRÖM, K. (1988). Control of replication of plasmid R1: Kinetics of in vitro interaction between the antisense RNA, CopA, and its target, CopT. EMBO J. 7, 3279-3288.
25. PERSSON, C., WAGNER, E.G.H., and NORDSTRÖM, K. (1990a). Control of replication of plasmid R1: Structures and sequences of the antisense RNA, CopA, required for its binding to the target RNA, CopT. EMBO J. 9, 3767-3775.
26. PERSSON, C., WAGNER, E.G.H., and NORDSTRÖM, K. (1990b). Control of replication of plasmid R1: Formation of an initial transient complex is rate-limiting for antisense RNA-target RNA pairing. EMBO J. 9, 3777-3785.
27. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring harbor, NY).
28. SCZAKIEL, G., PALU, G., and JAMES, W. (1997). Delivery of recombinant HIV-1-directed antisense and ribozyme genes. Methods Mol. Biol. 63, 389-400.
29. SYMONS, R.H. (1992). Small catalytic RNAs. Annu. Rev. Biochem. 61, 641-671.
30. TABLER, M., and TSAGRIS, M. (1991). Catalytic antisense RNAs produced by incorporating ribozyme cassettes into cDNA. Gene 108, 175-183.
31. TOMIZAWA, J.I. (1984). Control of ColE1 plasmid replication: The process of binding of RNA I to the primer transcript. Cell 38, 861-870.
32. TOMIZAWA, J.I. (1986). Control of ColE1 plasmid replication: Binding of RNA I to RNA II and inhibition of primer formation. Cell 47, 89-97.
33. TOMIZAWA, J. (1990). Control of ColE1 plasmid replication. Intermediates in the binding of RNA I and RNA II. J. Mol. Biol. 212, 683-694.
34. WAGNER, E.G.H., and SIMONS, R.W. (1994). Antisense RNA control in bacteria, phages and plasmids. Annu. Rev. Microbiol. 48, 713-742.